Clinical trial
Impact of Treatment With Autologous Plasma Rich in Growth Factors (PRGF) in Patients With Severe Dry Eye Disease.
NCT07773740 is registered in ClinicalTrials.gov with Gladys Lucia Silva Linares as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Treatment With Autologous Plasma Rich in Growth Factors (PRGF) in Patients With Severe Dry Eye Disease.
- Lead sponsor
- Gladys Lucia Silva Linares
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 25, 2026
- Completion date
- August 31, 2027
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
dry eye disease with severe keratitis